News
Hot off the Press
Discover news about Xcellerant Ventures, portfolio companies and the industry landcape.
Xcellerant Ventures News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Portfolio Company News
Nanodropper Forbes Profile
Content origionally posted on Forbes: https://www.forbes.com/profile/nanodropper/?sh=68bd9c044196 About Nanodropper Song, Baker, Andrews and Steger cofounded Nanodropper, a patented twist-on adapter that produces eye drops with 70% less volume than a normal eye drop,...
Health App That Tracks Response to Diseases Rated No. 1 by Cedars-Sinai Medical Center
Content origionally posted on The EPOCH Times: https://www.theepochtimes.com/us/health-app-that-tracks-response-to-diseases-rated-no-1-by-cedars-sinai-medical-center-4159309?welcomeuser=1 A unique health app that allows patients to track how treatments, medications,...
Local Doctor’s Prescription Addresses Environmental, Financial Concerns
Content origionally posted on Greenwich Sentinel: https://www.greenwichsentinel.com/2022/06/15/local-doctors-prescription-addresses-environmental-financial-concerns/ Like broken records, Dr. James Murphy’s patients had been bringing him the same repertoire of...
Eyes on the Patient
Content origionally posted on Mayo Clinic's blog: https://newsnetwork.mayoclinic.org/discussion/alumni-eyes-on-the-patient/ Editor's Note: This article is the first in the Young Innovators series, originally published in Mayo Clinic's Alumni Magazine. Each article...
John Shufeldt, MD, Joins Tesis Labs Board of Directors
Content origionally from PR News wire: https://www.prnewswire.com/news-releases/john-shufeldt-md-joins-tesis-labs-board-of-directors-301398790.html PHOENIX, Oct. 13, 2021 /PRNewswire/ -- Tesis Labs, a leader in targeted genetic sequencing, announced today the addition...
Tesis Labs Raises $20 Million in Growth Equity Capital to Expand Clinical Capacity
Content origionally from PR Newsire: https://www.prnewswire.com/news-releases/tesis-labs-raises-20-million-in-growth-equity-capital-to-expand-clinical-capacity-301392610.html PHOENIX, Oct. 5, 2021 /PRNewswire/ -- Tesis Labs, a leader in targeted genetic sequencing,...
Tesis Labs and Personal Genome Diagnostics Announce Collaboration to Advance Cancer Profiling and Treatment
Origionally on Business Wire: https://www.businesswire.com/news/home/20210810005333/en/Tesis-Labs-and-Personal-Genome-Diagnostics-Announce-Collaboration-to-Advance-Cancer-Profiling-and-Treatment BALTIMORE & HOUSTON--(BUSINESS WIRE)--Tesis Labs, a leader in...
FDA Clears One-Click Segmentation & Measurement Tool
Origionally posted on DeepLook Medical's Website: https://www.deeplookmedical.com/post/fda-clears-one-click-segmentation-measurement-tool The FDA has granted 510(k) clearance for DL PreciseTM, our one-click tool to automate segmentation and measurement of...
Rhode Island Based Startup, Lenoss Medical Raises $1.3 Million to Launch New Spinal Technology Challenging the Osseous Healing Paradigm
Blog origionally posted on RI Bio: https://ri-bio.org/rhode-island-based-startup-lenoss-medical-raises-1-3-million-to-launch-new-spinal-technology-challenging-the-osseous-healing-paradigm/ Providence, RI – May 5th, 2021 – Lenoss Medical, a biomedical start up focused...
Anuncia ReFlow™ Tech Honored With Fast Company 2021 World Changing Ideas Awards
Content origionally posted on PR Newswire: https://www.prnewswire.com/news-releases/anuncia-reflow-tech-honored-with-fast-company-2021-world-changing-ideas-awards-301283688.html LOWELL, Mass., May 4, 2021 /PRNewswire/ -- Anuncia Inc., an emerging leader in...
Nanodropper Completes $1.4 Million Seed Funding Round
Content oritionally posted on PR Newswire: https://www.prnewswire.com/news-releases/nanodropper-completes-1-4-million-seed-funding-round-301271892.html ROCHESTER, Minn., April 19, 2021 /PRNewswire/ -- Nanodropper, Inc., a medical device company offering a...
Tesis Labs Launching New Arizona Genetic Testing Facility
You can view this article at: https://www.prnewswire.com/news-releases/tesis-labs-launching-new-arizona-genetic-testing-facility-301264415.html
Why Xcellerant Ventures
We firmly believe that founders deserve more than just a check. In fact, investors should empower founds to help promote a vibrant ecosystem that allows groundbreaking ideas to enhance accessibility, efficiency, affordability, and quality of healthcare.
Futhermore, our GPs’ experience is unique and perfectly aligned with the needs of the market. They bring a combined experience of over seven decades in medical technologies, law, and entrepreneurship.
Through their personal experience, domain expertise, and unique network, they provide hands-on advice, education, and invaluable guidance to xcellerate startups and drive their success.
Founder Focus
We believe that the quality of the founders makes a huge difference in creating and fostering a successful partnership. We pick founders that are humble, willing to take advice, lead from the front, and are driven to change the world.
Moreover, we actively seek out founders and companies that have been overlooked by other venture capitalists, providing opportunities, expertise, and funding to individuals who have been traditionally underrepresented in the innovation economy.